Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 31722-165

5 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 31722-165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fosaprepitantstructure (Fosaprepitantstructure)

Fosaprepitantstructure (Fosaprepitantstructure)
Chemical structure of Fosaprepitant dimeglumine, the active ingredient in Fosaprepitant injection, powder, lyophilized, for solution. The diagram shows the molecular components including fluorinated aromatic rings and multiple hydroxyl groups.*
FDA Label Image
FDA Label Image
FDA Label Image

Fosaprepitantcartonlabel (Fosaprepitantcartonlabel)

Fosaprepitantcartonlabel (Fosaprepitantcartonlabel)
Packaging label for Fosaprepitant for Injection 150 mg per vial, lyophilized powder for intravenous use. The label includes instructions for reconstitution with 5 mL of 0.9% Sodium Chloride for Injection and cautions against use with certain solutions. It is manufactured by Aspiro Pharma Limited and labeled by Camber Pharmaceuticals, Inc. The label provides the NDC number 31722-165-31 and storage instructions for the vial.*
FDA Label Image

Fosaprepitantcontainerlabel (Fosaprepitantcontainerlabel)

Fosaprepitantcontainerlabel (Fosaprepitantcontainerlabel)
Label for Fosaprepitant for Injection 150 mg per vial, a single-dose vial containing sterile lyophilized powder for intravenous use. The label includes storage instructions to refrigerate at 2°C to 8°C and notes on drug stability after reconstitution. Manufactured by Aspiro Pharma Limited, India, for Camber Pharmaceuticals, Inc., Piscataway, NJ, with a U.S. contact number provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.